O'Brien P J, Li G
Human Safety Department, Miami Valley Laboratories, Procter and Gamble Company, Ross, Ohio 45081, USA.
Mol Cell Biochem. 1997 Feb;167(1-2):61-72. doi: 10.1023/a:1006867521140.
A microassay is demonstrated for functional characterization of the Ca(2+)-release channel (CRC) of sarcoplasmic reticulum (SR) of skeletal muscle using swine with susceptibility to malignant hyperthermia (MH). Diluted muscle homogenates, indo-1 and ratiometric dual-emission spectrofluorometry are used to monitor Ca(2+)-lowering activity in real-time in the presence and absence of ryanodine at exposures that open and close the CRC. Reactions are initiated with 50 microM CaCl2 to raise ionized Ca2+ concentration near 1 microM and MgATP to activate the Ca(2+)-ATPase pump. Oxalate is included to precipitate Ca2+ within the SR. The assay requires less than 30 mg muscle, which may be cryopreserved, and is completed within 20 min of thawing the tissue. Maximum SR Ca(2+)-ATPase pumping and CRC activities, degree of CRC activation, and Ca(2+)-buffering capacity can be determined. Using this assay we studied muscle from MH-susceptible swine and demonstrated that whereas maximal Ca(2+)-ATPase pumping and CRC activities are normal, the CRC activity after addition of a bolus of Ca2+ is 50% greater in heterozygotes and 100% greater in homozygotes for the MH mutation. Hypersensitivity to CRC agonists, such as caffeine, and an associated hyposensitivity to CRC antagonists such as Mg2+ is also demonstrated. Genotypes for the MH mutation site can be discriminated from each other by determining Ca(2+)-lowering activities and the effect of ryanodine on them.
本文展示了一种微量分析方法,用于对恶性高热(MH)易感猪骨骼肌肌浆网(SR)的钙释放通道(CRC)进行功能特性分析。使用稀释的肌肉匀浆、indo-1和比率双发射荧光光谱法,在存在和不存在ryanodine的情况下,于打开和关闭CRC的暴露条件下实时监测钙降低活性。反应以50 microM氯化钙启动,以提高离子化钙浓度至接近1 microM,并加入MgATP以激活钙ATP酶泵。加入草酸盐以沉淀SR内的钙。该分析所需肌肉少于30毫克,肌肉可冷冻保存,且在解冻组织后20分钟内即可完成。可测定SR最大钙ATP酶泵浦活性和CRC活性、CRC激活程度以及钙缓冲能力。使用该分析方法,我们研究了MH易感猪的肌肉,并证明虽然最大钙ATP酶泵浦活性和CRC活性正常,但对于MH突变的杂合子,加入大剂量钙后的CRC活性高50%,纯合子则高100%。还证明了对CRC激动剂(如咖啡因)的超敏反应以及对CRC拮抗剂(如Mg2+)的相关低敏反应。通过测定钙降低活性以及ryanodine对其的影响,可区分MH突变位点的基因型。